Stay updated on Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:40:26.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the study related to the safety and efficacy of Bermekimab in patients with moderate to severe Atopic Dermatitis.
    Difference
    0.1%
    Check dated 2024-06-06T14:41:15.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying inclusion and exclusion criteria such as age, health conditions, and prior treatments. This change provides more comprehensive information for researchers and potential participants about who can join the study.
    Difference
    51%
    Check dated 2024-05-22T21:38:37.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:46:52.000Z thumbnail image

Stay in the know with updates to Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.